Periodic Reporting for period 1 - HI-PRIX (Health Innovation Next Generation Payment & Pricing Models)

The emergence of high-price innovative therapies is exerting strong financial pressure on healthcare payers worldwide. Most of the recently approved advanced therapy medicinal products are for oncology indications, often in rare and ultra-rare populations. Given the high...